THERAPEUTIC HUMAN POLYCLONALS
THP is an emerging biotechnology company focused on research in the field of human antibody technologies. THP has developed a unique transgenic mammalian platform to create human antibodies. The technology will enable the generation of both monoclonal and polyclonal antibody therapeutics with enhanced efficacy.
Similar Organizations
PH Precision Med
PHPM is a privately-held clinical stage biotech company focused on developing imatinib for the treatment of pulmonary arterial hypertension.